Michael Freissmuth
5Patents
3h-index
13Co-inventors
50Inventor score
Filing activity: Jun 30, 2003 → Jan 27, 2016
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7527789B2 | Use of a preparation based on an antibody directed against a tumor-associated glycosylation | Chemistry; Metallurgy | 7 | Expired |
| US10086001B2 | Composition for the treatment of cystic fibrosis | Human Necessities | 6 | Active |
| US9504663B2 | Composition for the treatment of cystic fibrosis | Human Necessities | 3 | Active |
| US10213464B2 | Method for enhancing engraftment of haematopoetic stem cells | Emerging Cross-Sectional Technologies | 0 | Active |
| US10226465B2 | Composition for use in increasing engraftment efficacy of haematopoetic stem cells after transplantation | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.